How To Be Involved With the Pediatric Trials Network
- If you are a clinical site interested in joining the PTN, please complete our online survey. This survey allows the PTN team to better evaluate your site’s capabilities for potential involvement in future trials.
- If you are a clinical site and would like to more information about the PTN, please email us.
- If you are a PTN investigator and would like to submit a study proposal, complete this study concept proposal and send via email for PTN Executive Committee review.
Information About Pediatric Pharmacology
Considerations in the rational design and conduct of phase I/II pediatric clinical trials: avoiding the problems and pitfalls.
Abdel-Rahman SM, Reed MD, Wells TG, Kearns, GL
Clinical Pharmacology & Therapeutics, Volume 81, Number 4, 28 February 2007, Pages 483-494.
Understanding the relative roles of pharmacogenetics and ontogeny in pediatric drug development and regulatory science.
Leeder, JS, Kearns, GL, Spielberg, SP, van den Anker, J
The Journal of Clinical Pharmacology, Volume 50, Number 12, 11 February 2010, Pages 1377-1387.
Neville, KA, Becker, ML, Goldman, JL, Kearns, GL
Pediatric Anesthesia, Volume 21, Issue 3, March 2011, Pages 255-265.
Developmental pharmacology–drug disposition, action, and therapy in infants and children.
Kearns, GL, Abdel-Rahman, SM, Alander, SW, Blowey, DL, Leeder, JS, Kauffman, RE
New England Journal of Medicine Volume 349, September 2003, Pages 1157-1167.
The National Institutes of Health and the Best Pharmaceuticals for Children Act.
Pediatric Drugs, Volume 11, Issue 1, January 2009, Pages 45-47.